Glycemic response after oral ingestion of HBF2020-01 and HBF2020-03

Glycemic response after oral ingestion of HBF2020-01 and HBF2020-03 - Glycemic response after oral ingestion of HBF2020-01 and HBF2020-03

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000041406

Enrollment

Registered

2020-08-13

Start date

2020-08-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanease adults

Interventions

Oral ingestion of the test food HBF2020-01 Oral ingestion of glucose Oral ingestion of the test food HBF2020-03

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Healthy Japanease adults 2)Employees at the Hayashibara CO.,LTD. 3)Subjects who signed the informed consent for participation in the study 4)Individuals judged appropriate for the study by the principal investigator

Exclusion criteria

Exclusion criteria: 1)Subjects with medical fistory of sever disorders 2)Pregnant or have possibility to become pregnant during the study or lactating women 3)Subjects who judged as unsuitable for this study by the principal investigator for any reasons 4) Subjects who may affect the result of the study due to the medications 5) Subjects who are judged to have loose stools on a daily basis

Design outcomes

Primary

Measure	Time frame
Blood glucose level at 10, 20, 30, 40, 50, 60, 75, 90, 120 min after ingestion of HBF2020-01	—

Countries

Japan

Contacts

Public ContactAkiko Mizote

Hayashibara CO., LTD. R & D Division, Development Unit

akiko.mizote@hb.nagase.co.jp086-276-3141

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026